{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:12:18Z","timestamp":1780081938943,"version":"3.54.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["1401-2-209-58542"],"award-info":[{"award-number":["1401-2-209-58542"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11064-025-04584-8","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:30:25Z","timestamp":1761129025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antiseizure Effects of Mirtazapine in a Rat Model of Status Epilepticus Via Cannabinoid Receptor Modulation"],"prefix":"10.1007","volume":"50","author":[{"given":"Ali","family":"Vafaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1414-9063","authenticated-orcid":false,"given":"Mohammad Amin","family":"Manavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Toutounchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Mohaghegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh Mohammad","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Kharaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8001-5565","authenticated-orcid":false,"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"22","key":"4584_CR1","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","volume":"381","author":"J Kapur","year":"2019","unstructured":"Kapur J (2019) Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med 381(22):2103\u20132113","journal-title":"N Engl J Med"},{"issue":"5","key":"4584_CR2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1001\/jamaneurol.2024.0108","volume":"81","author":"YK Au","year":"2024","unstructured":"Au YK (2024) Treatment of refractory status epilepticus with continuous intravenous anesthetic drugs: a systematic review. JAMA Neurol 81(5):534\u2013548","journal-title":"JAMA Neurol"},{"issue":"7","key":"4584_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41582-022-00664-3","volume":"18","author":"RJ Burman","year":"2022","unstructured":"Burman RJ (2022) Why won\u2019t it stop? The dynamics of benzodiazepine resistance in status epilepticus. Nat Rev Neurol 18(7):428\u2013441","journal-title":"Nat Rev Neurol"},{"key":"4584_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.lfs.2016.11.006","volume":"168","author":"M Gooshe","year":"2017","unstructured":"Gooshe M et al (2017) Levosimendan exerts anticonvulsant properties against PTZ-induced seizures in mice through activation of nNOS\/NO pathway: role for K(ATP) channel. Life Sci 168:38\u201346","journal-title":"Life Sci"},{"issue":"16","key":"4584_CR5","doi-asserted-by":"publisher","first-page":"eadk4855","DOI":"10.1126\/sciadv.adk4855","volume":"10","author":"G Zilberg","year":"2024","unstructured":"Zilberg G et al (2024) Structural insights into the unexpected agonism of tetracyclic antidepressants at serotonin receptors 5-HT(1e)R and 5-HT(1F)R. Sci Adv 10(16):eadk4855","journal-title":"Sci Adv"},{"issue":"5","key":"4584_CR6","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1007\/s00210-023-02818-6","volume":"397","author":"EHM Hassanein","year":"2024","unstructured":"Hassanein EHM et al (2024) Pharmacological update of mirtazapine: a narrative literature review. Naunyn Schmiedebergs Arch Pharmacol 397(5):2603\u20132619","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"4584_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/15376516.2023.2231530","volume":"33","author":"SA Alharthy","year":"2023","unstructured":"Alharthy SA et al (2023) Mirtazapine attenuated cadmium-induced neuronal intoxication by regulating Nrf2 and NF-\u03baB\/TLR4 signals. Toxicol Mech Methods 33(8):675\u2013687","journal-title":"Toxicol Mech Methods"},{"key":"4584_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114296","volume":"442","author":"M Makov\u00e1","year":"2023","unstructured":"Makov\u00e1 M (2023) Mirtazapine modulates glutamate and GABA levels in the animal model of maternal depression. MRI and (1)H MRS study in female rats. Behav Brain Res 442:114296","journal-title":"Behav Brain Res"},{"key":"4584_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114553","volume":"161","author":"R Abdelhady","year":"2023","unstructured":"Abdelhady R (2023) Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model. Biomed Pharmacother 161:114553","journal-title":"Biomed Pharmacother"},{"key":"4584_CR10","doi-asserted-by":"publisher","first-page":"108174","DOI":"10.1016\/j.intimp.2021.108174","volume":"101","author":"HM Hafez","year":"2021","unstructured":"Hafez HM et al (2021) Protective effect of mirtazapine against acetic acid-induced ulcerative colitis in rats: role of NLRP3 inflammasome pathway. Int Immunopharmacol 101:108174","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"4584_CR11","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1111\/epi.18119","volume":"65","author":"I Ali","year":"2024","unstructured":"Ali I et al (2024) In vivo biomarkers of GABAergic function in epileptic rats treated with the GAT-1 inhibitor E2730. Epilepsia 65(11):3376\u20133390","journal-title":"Epilepsia"},{"issue":"1","key":"4584_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-025-00928-w","volume":"26","author":"A Vafaeian","year":"2025","unstructured":"Vafaeian A (2025) Molecular assessment of NMDAR subunits and neuronal apoptosis in the trigeminal ganglion in a model of male migraine-induced rats following Moringa oleifera alcoholic extract administration. BMC Neurosci 26(1):9","journal-title":"BMC Neurosci"},{"key":"4584_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106633","volume":"200","author":"V Aroniadou-Anderjaska","year":"2024","unstructured":"Aroniadou-Anderjaska V et al (2024) Alterations in GABA(A) receptor-mediated inhibition triggered by status epilepticus and their role in epileptogenesis and increased anxiety. Neurobiol Dis 200:106633","journal-title":"Neurobiol Dis"},{"issue":"1","key":"4584_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01153-2","volume":"9","author":"MA Sadeghi","year":"2021","unstructured":"Sadeghi MA et al (2021) Chronically altered NMDAR signaling in epilepsy mediates comorbid depression. Acta Neuropathol Commun 9(1):53","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"4584_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1089\/can.2023.0067","volume":"9","author":"M Masoumi","year":"2024","unstructured":"Masoumi M et al (2024) Cannabidiol anticonvulsant effects against Lithium-Pilocarpine-induced status epilepticus in male rats are mediated by neuroinflammation modulation and cannabinoids 1 (CB1), but not CB2 and GABA(A) receptors. Cannabis Cannabinoid Res 9(3):797\u2013808","journal-title":"Cannabis Cannabinoid Res"},{"key":"4584_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yebeh.2019.01.025","volume":"93","author":"A Haj-Mirzaian","year":"2019","unstructured":"Haj-Mirzaian A (2019) Activation of ATP-sensitive K-channel promotes the anticonvulsant properties of cannabinoid receptor agonist through mitochondrial ATP level reduction. Epilepsy Behav 93:1\u20136","journal-title":"Epilepsy Behav"},{"issue":"1","key":"4584_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.eplepsyres.2008.04.010","volume":"81","author":"A Bahremand","year":"2008","unstructured":"Bahremand A et al (2008) The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose Naltrexone in mice. Epilepsy Res 81(1):44\u201351","journal-title":"Epilepsy Res"},{"key":"4584_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pnpbp.2014.11.005","volume":"57","author":"B Payandemehr","year":"2015","unstructured":"Payandemehr B (2015) Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2. Prog Neuropsychopharmacol Biol Psychiatry 57:140\u2013145","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"11","key":"4584_CR19","first-page":"5303","volume":"27","author":"J D\u00edaz-Alonso","year":"2017","unstructured":"D\u00edaz-Alonso J et al (2017) Loss of cannabinoid CB1 receptors induces cortical migration malformations and increases seizure susceptibility. Cereb Cortex 27(11):5303\u20135317","journal-title":"Cereb Cortex"},{"issue":"Pt 11","key":"4584_CR20","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/brain\/awp239","volume":"132","author":"J Palazuelos","year":"2009","unstructured":"Palazuelos J (2009) Microglial CB2 cannabinoid receptors are neuroprotective in Huntington\u2019s disease excitotoxicity. Brain 132(Pt 11):3152\u20133164","journal-title":"Brain"},{"key":"4584_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114679","volume":"373","author":"AA Karan","year":"2024","unstructured":"Karan AA et al (2024) Distant neuroinflammation acutely induced by focal brain injury and its control by endocannabinoid system. Exp Neurol 373:114679","journal-title":"Exp Neurol"},{"issue":"6","key":"4584_CR22","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1007\/s12035-020-01923-4","volume":"57","author":"Y Yu","year":"2020","unstructured":"Yu Y et al (2020) Inverse agonism of cannabinoid receptor type 2 confers anti-inflammatory and neuroprotective effects following status epileptics. Mol Neurobiol 57(6):2830\u20132845","journal-title":"Mol Neurobiol"},{"key":"4584_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae157","author":"ME Burkart","year":"2024","unstructured":"Burkart ME (2024) Katp channel mutation disrupts hippocampal network activity and nocturnal gamma shifts. Brain. https:\/\/doi.org\/10.1093\/brain\/awae157","journal-title":"Brain"},{"issue":"11","key":"4584_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11375","volume":"8","author":"MA Manavi","year":"2022","unstructured":"Manavi MA et al (2022) Anticonvulsant effects of ivermectin on pentylenetetrazole- and maximal electroshock-induced seizures in mice: the role of GABAergic system and K(ATP) channels. Heliyon 8(11):e11375","journal-title":"Heliyon"},{"key":"4584_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04061-3","author":"MA Manavi","year":"2024","unstructured":"Manavi MA (2024) Ivermectin exerts anticonvulsant effects against status epilepticus induced by lithium-pilocarpine in rats via GABA(A) receptor and neuroinflammation modulation: possible interaction of opioidergic pathways and K(ATP) channel with nitrergic system. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04061-3","journal-title":"Mol Neurobiol"},{"key":"4584_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108262","volume":"123","author":"S Agarwal","year":"2021","unstructured":"Agarwal S et al (2021) Effect of lacosamide on neuroinflammation-mediated seizures comorbid with depression in C57BL\/6 mice- role of kynurenine pathway. Epilepsy Behav 123:108262","journal-title":"Epilepsy Behav"},{"key":"4584_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.638854","volume":"15","author":"N Deng","year":"2021","unstructured":"Deng N et al (2021) Indoleamine-2,3-dioxygenase 1 deficiency suppresses seizures in epilepsy. Front Cell Neurosci 15:638854","journal-title":"Front Cell Neurosci"},{"key":"4584_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177073","volume":"985","author":"L Garc\u00eda-Garc\u00eda","year":"2024","unstructured":"Garc\u00eda-Garc\u00eda L (2024) Dantrolene paradoxically exacerbates short-term brain glucose hypometabolism, hippocampal damage and neuroinflammation induced by status epilepticus in the rat lithium-pilocarpine model. Eur J Pharmacol 985:177073","journal-title":"Eur J Pharmacol"},{"key":"4584_CR29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ejphar.2017.10.002","volume":"815","author":"SM Eslami","year":"2017","unstructured":"Eslami SM et al (2017) Involvement of nitrergic system in anticonvulsant effect of Zolpidem in lithium-pilocarpine induced status epilepticus: evaluation of iNOS and COX-2 genes expression. Eur J Pharmacol 815:454\u2013461","journal-title":"Eur J Pharmacol"},{"key":"4584_CR30","doi-asserted-by":"publisher","first-page":"106563","DOI":"10.1016\/j.yebeh.2019.106563","volume":"101","author":"S Meskinimood","year":"2019","unstructured":"Meskinimood S et al (2019) Modulatory effect of opioid ligands on status epilepticus and the role of nitric oxide pathway. Epilepsy Behav 101:106563","journal-title":"Epilepsy Behav"},{"issue":"1","key":"4584_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/fcp.12590","volume":"35","author":"F Eslami","year":"2021","unstructured":"Eslami F (2021) Sumatriptan reduces severity of status epilepticus induced by lithium-pilocarpine through nitrergic transmission and 5-HT(1B\/D) receptors in rats: a pharmacological-based evidence. Fundam Clin Pharmacol 35(1):131\u2013140","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"4584_CR32","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s43440-022-00387-8","volume":"74","author":"F Eslami","year":"2022","unstructured":"Eslami F et al (2022) Pentylenetetrazole preconditioning attenuates severity of status epilepticus induced by lithium-pilocarpine in male rats: evaluation of opioid\/NMDA receptors and nitric oxide pathway. Pharmacol Rep 74(4):602\u2013613","journal-title":"Pharmacol Rep"},{"key":"4584_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2022.108649","volume":"130","author":"F Moradi","year":"2022","unstructured":"Moradi F et al (2022) Modafinil exerts anticonvulsive effects against lithium-pilocarpine-induced status epilepticus in rats: a role for tumor necrosis factor-\u03b1 and nitric oxide signaling. Epilepsy Behav 130:108649","journal-title":"Epilepsy Behav"},{"issue":"9","key":"4584_CR34","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s11064-013-1103-3","volume":"38","author":"X Liu","year":"2013","unstructured":"Liu X et al (2013) Repeated administration of mirtazapine attenuates oxaliplatin-induced mechanical allodynia and spinal NR2B up-regulation in rats. Neurochem Res 38(9):1973\u20131979","journal-title":"Neurochem Res"},{"issue":"12","key":"4584_CR35","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1007\/s11064-024-04240-7","volume":"49","author":"SH Aghili","year":"2024","unstructured":"Aghili SH (2024) Mirtazapine improves locomotor activity and attenuates neuropathic pain following spinal cord injury in rats via neuroinflammation modulation. Neurochem Res 49(12):3326\u20133341","journal-title":"Neurochem Res"},{"issue":"1","key":"4584_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yebeh.2007.04.004","volume":"11","author":"I Yilmaz","year":"2007","unstructured":"Yilmaz I et al (2007) Mirtazapine does not affect pentylenetetrazole- and maximal electroconvulsive shock-induced seizures in mice. Epilepsy Behav 11(1):1\u20135","journal-title":"Epilepsy Behav"},{"key":"4584_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/JIR.S258991","volume":"13","author":"S Hemmati","year":"2020","unstructured":"Hemmati S et al (2020) Protective effects of Leukadherin1 in a rat model of targeted experimental autoimmune encephalomyelitis (EAE): possible role of P47phox and MDA downregulation. J Inflamm Res 13:411\u2013420","journal-title":"J Inflamm Res"},{"issue":"9","key":"4584_CR38","doi-asserted-by":"publisher","first-page":"e14892","DOI":"10.1111\/cns.14892","volume":"30","author":"A Vafaei","year":"2024","unstructured":"Vafaei A et al (2024) Effects of beta-sitosterol on anxiety in migraine-induced rats: the role of oxidative\/nitrosative stress and mitochondrial function. CNS Neurosci Ther 30(9):e14892","journal-title":"CNS Neurosci Ther"},{"key":"4584_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12589-6","author":"Q Calonge","year":"2024","unstructured":"Calonge Q (2024) Burden of status epilepticus: prognosis and cost driving factors, insight from a nationwide retrospective cohort study of the French health insurance database. J Neurol. https:\/\/doi.org\/10.1007\/s00415-024-12589-6","journal-title":"J Neurol"},{"issue":"5","key":"4584_CR40","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/epi.17927","volume":"65","author":"SW Terman","year":"2024","unstructured":"Terman SW et al (2024) Hospital variation of outcomes in status epilepticus. Epilepsia 65(5):1415\u20131427","journal-title":"Epilepsia"},{"issue":"1","key":"4584_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04858-7","volume":"28","author":"F Stretti","year":"2024","unstructured":"Stretti F (2024) Long-term outcome in new onset refractory status epilepticus: a retrospective study. Crit Care 28(1):72","journal-title":"Crit Care"},{"issue":"8","key":"4584_CR42","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/epi.18035","volume":"65","author":"N Chiriboga","year":"2024","unstructured":"Chiriboga N, Spentzas T, Abu-Sawwa R (2024) A systematic review and meta-analysis of ketamine in pediatric status epilepticus. Epilepsia 65(8):2200\u20132212","journal-title":"Epilepsia"},{"key":"4584_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114551","volume":"452","author":"AT Che Has","year":"2023","unstructured":"Che Has AT (2023) The applications of the pilocarpine animal model of status epilepticus: 40 years of progress (1983\u20132023). Behav Brain Res 452:114551","journal-title":"Behav Brain Res"},{"issue":"7","key":"4584_CR44","doi-asserted-by":"publisher","first-page":"e04557","DOI":"10.1016\/j.heliyon.2020.e04557","volume":"6","author":"J Ahmed","year":"2020","unstructured":"Ahmed J, II and, Che AT, Has (2020) The evolution of the pilocarpine animal model of status epilepticus. Heliyon 6(7):e04557","journal-title":"Heliyon"},{"key":"4584_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108030","volume":"170","author":"C Ramon-Duaso","year":"2020","unstructured":"Ramon-Duaso C et al (2020) Protective effects of Mirtazapine in mice lacking the Mbnl2 gene in forebrain glutamatergic neurons: relevance for myotonic dystrophy 1. Neuropharmacology 170:108030","journal-title":"Neuropharmacology"},{"issue":"6","key":"4584_CR46","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.pjnns.2018.07.005","volume":"52","author":"N G\u00f3rska","year":"2018","unstructured":"G\u00f3rska N et al (2018) Antidepressants in epilepsy. Neurol Neurochir Pol 52(6):657\u2013661","journal-title":"Neurol Neurochir Pol"},{"key":"4584_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104675","volume":"137","author":"W Lazarini-Lopes","year":"2022","unstructured":"Lazarini-Lopes W, Silva-Cardoso GK (2022) Neuroplastic alterations in cannabinoid receptors type 1 (CB1) in animal models of epileptic seizures. Neurosci Biobehav Rev 137:104675","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"4584_CR48","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1021\/acschemneuro.9b00080","volume":"10","author":"R Di Maio","year":"2019","unstructured":"Di Maio R, Colangeli R, Di Giovanni G (2019) WIN 55,212-2 reverted pilocarpine-induced status epilepticus early changes of the interaction among 5-HT(2 C)\/NMDA\/CB(1) receptors in the rat hippocampus. ACS Chem Neurosci 10(7):3296\u20133306","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"4584_CR49","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1528-1167.2012.03460.x","volume":"53","author":"KW Sayers","year":"2012","unstructured":"Sayers KW (2012) Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain. Epilepsia 53(5):897\u2013907","journal-title":"Epilepsia"},{"key":"4584_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.seizure.2018.03.009","volume":"57","author":"J Tchekalarova","year":"2018","unstructured":"Tchekalarova J et al (2018) Pharmacological characterization of the cannabinoid receptor 2 agonist, \u03b2-caryophyllene on seizure models in mice. Seizure 57:22\u201326","journal-title":"Seizure"},{"key":"4584_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eplepsyres.2018.10.002","volume":"148","author":"Q Wu","year":"2018","unstructured":"Wu Q, Wang H (2018) The spatiotemporal expression changes of CB2R in the hippocampus of rats following pilocarpine-induced status epilepticus. Epilepsy Res 148:8\u201316","journal-title":"Epilepsy Res"},{"key":"4584_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.814066","volume":"12","author":"MJC Houtman","year":"2022","unstructured":"Houtman MJC (2022) Development of I(KATP) ion channel blockers targeting sulfonylurea resistant mutant K(IR)6.2 based channels for treating DEND syndrome. Front Pharmacol 12:814066","journal-title":"Front Pharmacol"},{"issue":"12","key":"4584_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028208","volume":"6","author":"T Kobayashi","year":"2011","unstructured":"Kobayashi T, Washiyama K, Ikeda K (2011) Inhibition of G protein-activated inwardly rectifying K\u2009+\u2009channels by different classes of antidepressants. PLoS ONE 6(12):e28208","journal-title":"PLoS ONE"},{"issue":"3","key":"4584_CR54","first-page":"256","volume":"7","author":"M Sala","year":"2006","unstructured":"Sala M et al (2006) Antidepressants: their effects on cardiac channels, QT prolongation and torsade de pointes. Curr Opin Investig Drugs 7(3):256\u2013263","journal-title":"Curr Opin Investig Drugs"},{"issue":"2","key":"4584_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0361-9230(92)90184-Y","volume":"28","author":"L V\u00e9csei","year":"1992","unstructured":"V\u00e9csei L (1992) Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain. Brain Res Bull 28(2):233\u2013238","journal-title":"Brain Res Bull"},{"issue":"12","key":"4584_CR56","doi-asserted-by":"publisher","first-page":"10409","DOI":"10.1007\/s11033-023-08859-7","volume":"50","author":"M Sheibani","year":"2023","unstructured":"Sheibani M (2023) Kynurenine pathway and its role in neurologic, psychiatric, and inflammatory bowel diseases. Mol Biol Rep 50(12):10409\u201310425","journal-title":"Mol Biol Rep"},{"issue":"6","key":"4584_CR57","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.brainresbull.2008.10.010","volume":"78","author":"P Maciejak","year":"2009","unstructured":"Maciejak P (2009) Time course of changes in the concentration of kynurenic acid in the brain of pentylenetetrazol-kindled rats. Brain Res Bull 78(6):299\u2013305","journal-title":"Brain Res Bull"},{"issue":"6","key":"4584_CR58","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S1734-1140(11)70723-X","volume":"63","author":"P Maciejak","year":"2011","unstructured":"Maciejak P et al (2011) Kynurenic acid: a new effector of valproate action? Pharmacol Rep 63(6):1569\u20131573","journal-title":"Pharmacol Rep"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04584-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04584-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04584-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:02:48Z","timestamp":1764741768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04584-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4584"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04584-8","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}},{"value":"All criteria issued by TUMS Ethical Council were followed closely for conducting procedures involving animals (Ethical Code: IR.TUMS.MEDICINE.REC.1401.450).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"331"}}